Rebecca E. Wolitz

Ohio State University (OSU) - Michael E. Moritz College of Law

55 West 12th Avenue

Columbus, OH 43210

United States

SCHOLARLY PAPERS

6

DOWNLOADS

215

SSRN CITATIONS

2

CROSSREF CITATIONS

0

Scholarly Papers (6)

1.

Legal Strategies for Reining in 'Unconscionable' Prices for Prescription Drugs

Northwestern University Law Review, Vol. 114, No. 5, 2020, Forthcoming
Number of pages: 74 Posted: 23 Jul 2019 Last Revised: 07 Aug 2019
Michelle M. Mello and Rebecca E. Wolitz
Stanford Law School and Ohio State University (OSU) - Michael E. Moritz College of Law
Downloads 159 (278,516)
Citation 2

Abstract:

Loading...

prescription drugs, medicines, prices, regulation, vagueness, health policy

2.

States, Preemption, and Patented Drug Prices

Seton Hall Law Review, Vol. 52, No. 2, 2021, Ohio State Legal Studies Research Paper No. 669
Number of pages: 75 Posted: 16 Nov 2021 Last Revised: 13 Jan 2023
Rebecca E. Wolitz
Ohio State University (OSU) - Michael E. Moritz College of Law
Downloads 45 (602,875)

Abstract:

Loading...

drug pricing, patents, states, health law, innovation policy

3.

A Corporate Duty to Rescue: Biopharmaceutical Companies and Access to Medications

Indiana Law Journal, 2019, Forthcoming, Stanford Public Law Working Paper
Number of pages: 60 Posted: 26 Jun 2018 Last Revised: 15 Nov 2021
Rebecca E. Wolitz
Ohio State University (OSU) - Michael E. Moritz College of Law
Downloads 10 (858,088)

Abstract:

Loading...

Access to Medications, Drug-pricing, Corporate Governance, Health Law, Intellectual Property, Bioethics

4.

Refocusing the Responsiveness Requirement

Bioethics, Vol. 27, Issue 3, pp. 151-159, 2013
Number of pages: 9 Posted: 15 Feb 2013
Seema K. Shah, Rebecca E. Wolitz and Ezekiel J. Emanuel
National Institutes of Health - Department of Bioethics, Ohio State University (OSU) - Michael E. Moritz College of Law and Government of the United States of America - Department of Clinical Bioethics
Downloads 1 (957,575)

Abstract:

Loading...

international research ethics, global health, priority setting, responsiveness

5.

Government Patent Use to Promote Public Health in the United States: Overcoming Nonpatent Exclusivities

American Journal of Public Health (2022)
Posted: 11 Jul 2022
Rebecca E. Wolitz, Aaron S. Kesselheim and Jonathan J. Darrow
Ohio State University (OSU) - Michael E. Moritz College of Law, Brigham and Women's Hospital/Harvard Medical School and affiliation not provided to SSRN

Abstract:

Loading...

access to medications, patent law, FDA, non-patent exclusivities, Section 1498

6.

The Pay-Twice Critique, Government Funding, and Reasonable Pricing Clauses

Georgia State University, College of Law Journal of Legal Medicine Symposium, 2019, Forthcoming
Posted: 24 Aug 2019
Rebecca E. Wolitz
Ohio State University (OSU) - Michael E. Moritz College of Law

Abstract:

Loading...

Drug Pricing, Access to Medicines, Federal Funding, Innovation Policy, NIH